Mar 07, 2022 / 07:50PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Well, good afternoon, and welcome to the Elanco session at Cowen's 42nd Annual Healthcare Conference. We're very, very pleased to have back with us again this year, Jeff Simmons, who is President and CEO of Elanco. Elanco is a leading company with a strong position in a vibrant market. So it's a very interesting and attractive idea, in our opinion. Lots to talk about in the next hour or half hour. So we'll get started.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystJeff, thank you for spending the time with us. I'd like to start out with a thing that's kind of top of mind, and that is the situation -- unfortunate situation in Russia and Ukraine, just to deal with the issue at the start. So what is Elanco's position in these markets? What is your exposure both from the operational standpoint, but also what is your exposure from the supply chain pressures -- potential pressures?
Trustpilot
